Company Overview and News

 
Compumedics' shares soar on China expansion

2018-05-31 proactiveinvestors.com.au
Compumedics Ltd's (ASX:CMP) shares have soared 71% to $0.70 in the first hour of trade, with two million changing hands.
CMP

 
Compumedics has a third party contract on the table from China

2018-05-28 proactiveinvestors.com.au
Compumedics Ltd (ASX:CMP) recently entered into three-year distribution contracts with three existing, long-term, China-based, sleep and neuro-diagnostic and monitoring distributors.
CMP ASXFF ASXFY

4
Compumedics provides upbeat profit guidance resulting in 12% share price re-rating

2018-03-21 proactiveinvestors.com.au
Compumedics Limited (ASX:CMP) appears to be bouncing back after a decline in its share price which started in the second half of 2017.
CMP TUES

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:CMP / COMPUMEDICS LIMITED on message board site Silicon Investor.

Moyco CMP Slurries - CEO Says Moyco CMP Slurries - CEO Says Moyco CMP Slurries - CEO Says Cabot Microelectronics -- CCMP Cabot Microelectronics -- CCMP Cabot Microelectronics -- CCMP
Computone (CMPT) Computone (CMPT) Computone (CMPT) CMP CMP CMP
Compumed (CMPDC) Compumed (CMPDC) Compumed (CMPDC) CMPDC: Compumed, Inc. CMPDC: Compumed, Inc. CMPDC: Compumed, Inc.
UNICOMP (UCMP) UNICOMP (UCMP) UNICOMP (UCMP) VCampus Corporation (VCMP) VCampus Corporation (VCMP) VCampus Corporation (VCMP)
CMPX: CMP MEDIA...The Unknown Internet Media Giant CMPX: CMP MEDIA...The Unknown Internet Media Giant CMPX: CMP MEDIA...The Unknown Internet Media Giant Computer Literacy - CMPL- Where will it go? Computer Literacy - CMPL- Where will it go? Computer Literacy - CMPL- Where will it go?